ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 71 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184,243 | -28.2% | 90,760 | -18.6% | 0.00% | – |
| Q2 2023 | $256,501 | -3.8% | 111,522 | +26.8% | 0.00% | – |
| Q1 2023 | $266,570 | +54.0% | 87,977 | +18.4% | 0.00% | – |
| Q4 2022 | $173,064 | +64.8% | 74,276 | +34.6% | 0.00% | – |
| Q3 2022 | $105,000 | +1.0% | 55,184 | +43.5% | 0.00% | – |
| Q2 2022 | $104,000 | -27.3% | 38,456 | -19.5% | 0.00% | – |
| Q1 2022 | $143,000 | -97.0% | 47,763 | -96.1% | 0.00% | – |
| Q4 2021 | $4,715,000 | -41.8% | 1,211,897 | -35.9% | 0.00% | -100.0% |
| Q3 2021 | $8,104,000 | +411.0% | 1,889,185 | +261.0% | 0.00% | – |
| Q2 2021 | $1,586,000 | +26.6% | 523,384 | +39.1% | 0.00% | – |
| Q1 2021 | $1,253,000 | +6861.1% | 376,248 | +7374.1% | 0.00% | – |
| Q4 2020 | $18,000 | +100.0% | 5,034 | +67.7% | 0.00% | – |
| Q3 2020 | $9,000 | -90.9% | 3,001 | -94.5% | 0.00% | – |
| Q2 2020 | $99,000 | +80.0% | 54,599 | +0.1% | 0.00% | – |
| Q1 2020 | $55,000 | +120.0% | 54,549 | +497.7% | 0.00% | – |
| Q4 2019 | $25,000 | -83.7% | 9,127 | -90.9% | 0.00% | – |
| Q3 2019 | $153,000 | -50.0% | 100,458 | -31.9% | 0.00% | – |
| Q2 2019 | $306,000 | +800.0% | 147,493 | +1452.1% | 0.00% | – |
| Q1 2019 | $34,000 | -69.9% | 9,503 | -67.6% | 0.00% | – |
| Q4 2018 | $113,000 | -57.7% | 29,360 | +3.9% | 0.00% | – |
| Q3 2018 | $267,000 | +310.8% | 28,262 | +219.4% | 0.00% | – |
| Q2 2018 | $65,000 | +306.2% | 8,849 | +184.1% | 0.00% | – |
| Q1 2018 | $16,000 | -72.4% | 3,115 | -73.0% | 0.00% | – |
| Q4 2017 | $58,000 | +383.3% | 11,544 | +492.0% | 0.00% | – |
| Q3 2017 | $12,000 | +71.4% | 1,950 | 0.0% | 0.00% | – |
| Q2 2017 | $7,000 | +16.7% | 1,950 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | 0.0% | 1,950 | -20.4% | 0.00% | – |
| Q4 2016 | $6,000 | -14.3% | 2,450 | +25.6% | 0.00% | – |
| Q3 2016 | $7,000 | +16.7% | 1,950 | +5.4% | 0.00% | – |
| Q2 2016 | $6,000 | -25.0% | 1,850 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -94.5% | 1,850 | -94.4% | 0.00% | – |
| Q4 2015 | $146,000 | -27.4% | 32,869 | -0.6% | 0.00% | – |
| Q3 2015 | $201,000 | – | 33,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |